NSE: MASTEK | BSE: 523704

Strong Performer, Under Radar

Download real time

1679.90 28.70 (1.74%)

29.09% Fall from 52W High

206.7K NSE+BSE Volume

NSE 09 Oct, 2026 3:31 PM (IST)

5,208.8

Market Cap

High in industry

Beta 1Year

Very High Volatility

Mastek Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MASTEK, BSE:523704 Mastek Ltd.

Search Inside the pdf :

Mastek Ltd.

22 Jul 2026

1679.90

1.74%

Strong order book yet growth conversion remains elusive Q 1F Y2 7 performance : Revenue stood at US$104.8 mn, up 1.2% QoQ / down 2.4% YoY (up 1.8% QoQ CC / down 3% YoY CC). EBITDA margin for the quarter stood at 15.3%, down ~71 bps QoQ, impacted by delayed collections in the Middle East. The...

Mastek Ltd. is trading above its 150 day SMA of 1648.1

Mastek Ltd.

22 Apr 2026

1679.90

1.74%

Mastek Ltd.

Sell: Mastek Ltd.

Recommendation Target

ICICI Direct

Q4FY26 & FY26 Performance: Revenue stood at US$103.5 mn, up 1.4% QoQ / down 1.1% YoY (up 0.3% QoQ CC / down 5.8% YoY CC). EBITDA margin for the quarter stood at 16.1%, down ~71 bps QoQ, impacted by wage hikes and labour code true-ups. The PAT for the quarter stood at 106.2 crore, down 2% QoQ / up 30.9% YoY. For FY26 revenue stood at US$421.2 mn, up 3.1% YoY (-0.2% YoY CC)....

Mastek Ltd. is trading above its 150 day SMA of 1648.1

Mastek Ltd.

20 Apr 2026

1679.90

1.74%

Setting the stage for a resilient FY27 after a year of reset; maintain BUY

Buy: Mastek Ltd.

Target

Anand Rathi

Notwithstanding macro and geopolitical headwinds, Mastek reported an in-line performance in Q4FY26, with CC revenue growing by 0.3% q/q to $103.5m and a robust 13.6% y/y growth in 12m order backlog.

Mastek Ltd. is trading above its 150 day SMA of 1648.1

Mastek Ltd.

22 Jan 2026

1679.90

1.74%

Mastek Ltd.

Hold: Mastek Ltd.

Recommendation Target

ICICI Direct

Margin resilience and improving fundamentals support upside: Despite revenue headwinds, Mastek delivered sequential margin expansion. Adjusted profitability too improved (80 bps QoQ to 16.3%) even after factoring in seasonal furloughs and labour code impacts, underscoring execution resilience driven by AI-led operational efficiencies, lower subcontracting and disciplined cost management (43 bps) and forex (17 bps). The management has guided to maintain margins in the band of 16.5-17%. We model EBITDA margins at...

Mastek Ltd. is trading below its 50 day SMA of 1701.9

Mastek Ltd.

17 Nov 2025

1679.90

1.74%

MASTEK LTD

Buy: Mastek Ltd.

Target

Geojit BNP Paribas

Mastek Ltd is a Mumbai-based global provider of digital engineering and cloud transformation services, operating in over 40 countries. It partners with Oracle, Salesforce, Microsoft, AWS, and Snowflake to deliver consulting, data analytics, and enterprise solutions. The UK and Europe contribute 64% of revenue, followed by the US and the Middle East. Sector-wise, Government and Education lead with 39%, Healthcare contributes 25%, while Retail, Manufacturing, and...

Number of FII/FPI investors decreased from 144 to 136 in Jun 2026 qtr

Mastek Ltd.

20 Oct 2025

1679.90

1.74%

Mastek Ltd

Buy: Mastek Ltd.

Target

ICICI Direct

About the stock: Mastek Ltd (Mastek) offers data, apps, cloud services to public Geographic strength and strategic focus areas: UK remains Mastek's growth anchor, up 4% QoQ and contributing 65% of revenue, driven by strong demand in Healthcare and Government segments. The company is also restructuring its North America leadership to drive Healthcare growth and emphasis remains on profitability improvement and tighter DSO management.in the Middle East. Continued focus on geo-diversification, AI-led delivery, and mid-market leadership provides visibility for steady, profitable growth through FY2627...

Number of FII/FPI investors decreased from 144 to 136 in Jun 2026 qtr

Mastek Ltd.

22 Jul 2025

1679.90

1.74%

MASTEK LTD

Buy: Mastek Ltd.

Geojit BNP Paribas

Mastek Ltd is a Mumbai-based global provider of digital engineering and cloud transformation services, operating in over 40 countries. It partners with Oracle, Salesforce, Microsoft, AWS, and Snowflake to deliver consulting, data analytics, and enterprise solutions. The UK and Europe contribute 64% of revenue, followed by the US and Middle East. Sector-wise, Government and Education lead with 39%,...

Mastek Ltd. is trading below its 50 day SMA of 1701.9

Mastek Ltd.

22 Jul 2025

1679.90

1.74%

Mastek: Resilient UK, as NA & AMEA drag. Is this the inflection point? Retaining a Buy

Buy: Mastek Ltd.

Target

Anand Rathi

Mastek’s Q1FY26 performance highlights ongoing execution challenges in NA and AMEA, with CC revenue declining -1.1% q/q, reflecting transition issues coupled with Payer and Retail-client-specific concerns in the US.

Number of FII/FPI investors decreased from 144 to 136 in Jun 2026 qtr

Mastek Ltd.

21 Apr 2025

1679.90

1.74%

Mixed Quarter, UK to drive growth

Buy: Mastek Ltd.

Sharekhan

Reported revenues stood at $104.6 million, up 2.9% q-o-q in constant currency (CC) terms, beating our estimates of 1.8% q-o-q growth in CC driven by core business in UK and Europe.

Mastek Ltd. is trading below its 50 day SMA of 1701.9

Mastek Ltd.

21 Mar 2025

1679.90

1.74%

Growth momentum to continue amid merger challenges

Buy: Mastek Ltd.

Sharekhan

We participated in a conference call organised by Mastek’s management to address the concerns stemming from the abolishment of NHS England on account of its merger with the Department of Health and Social Care (DHSC).

Number of FII/FPI investors decreased from 144 to 136 in Jun 2026 qtr

Is Mastek Ltd. worth buying?

218 Votes:

Buy 76.15%

Sell 16.51%

Hold 7.34%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf

Sell SEE REPORTS >

pdf